ECHS1 interacts with STAT3 and negatively regulates STAT3 signaling

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in cellular processes.
• Over-activation of STAT3 is frequently observed in various human tumors, highlighting its significance in cancer.
• The precise regulatory mechanisms governing STAT3 activation remain incompletely understood.

Purpose of the Study:

• To identify novel proteins that interact with STAT3.
• To elucidate the role of identified proteins in regulating STAT3 activity and signaling.
• To provide new insights into the molecular mechanisms controlling STAT3 function in cellular processes and cancer.

Main Methods:

• Yeast two-hybrid screening was employed to identify potential STAT3 binding partners.
• Protein-protein interactions were confirmed using biochemical assays such as GST-pull down and co-immunoprecipitation.
• The effect of the identified protein on STAT3 activity and target gene expression was assessed, including STAT3 phosphorylation levels.

Main Results:

• Enoyl-CoA hydratase short chain 1 (ECHS1) was identified as a novel binding protein for STAT3.
• The interaction between ECHS1 and STAT3 was experimentally validated.
• ECHS1 was found to specifically repress STAT3 transcriptional activity by inhibiting STAT3 phosphorylation, leading to negative regulation of STAT3 target genes.

Conclusions:

• ECHS1 is a novel negative regulator of STAT3 signaling.
• The interaction between ECHS1 and STAT3 provides a new mechanism for controlling STAT3 activity.
• These findings contribute to a deeper understanding of STAT3 regulation and may offer potential therapeutic targets for STAT3-driven cancers.